Literature DB >> 5689413

Asparagine synthetase activity of mouse leukemias.

B Horowitz, B K Madras, A Meister, L J Old, E A Boyes, E Stockert.   

Abstract

Various transplanted leukemias and normal tissues of the mouse were tested for asparagine synthetase activity. Leukemias susceptible to suppression by asparaginase have little or no synthetase activity. In contrast, leukemias insensitive to asparaginase exhibit substantial and often very high asparagine synthetase activity. Asparaginase-resistant variants of sensitive leukemias also have considerable synthetase activity. Thus the requirement by certain malignant cells of exogenous asparagine, which entails sensitivity to asparaginase, may be ascribed to lack of asparagine synthetase. Development of asparaginase-resistant variants from asparaginase-sensitive lines is consistently associated with acquisition of asparagine synthetase activity.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5689413     DOI: 10.1126/science.160.3827.533

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  45 in total

1.  Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.

Authors:  Jason R Cantor; Tae Hyeon Yoo; Aakanksha Dixit; Brent L Iverson; Thomas G Forsthuber; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-05       Impact factor: 11.205

2.  Modulation of lymphocyte proliferation by enzymes that degrade amino acids.

Authors:  J C Chuang; C L Yu; S R Wang
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.

Authors:  S-H Chen; W Yang; Y Fan; G Stocco; K R Crews; J J Yang; S W Paugh; C-H Pui; W E Evans; M V Relling
Journal:  Leukemia       Date:  2010-11-12       Impact factor: 11.528

Review 4.  Asparagine synthetase chemotherapy.

Authors:  Nigel G J Richards; Michael S Kilberg
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

5.  An investigation into the mechanism ofL-asparaginase resistance in L5178Y murine leukemia cells.

Authors:  J K Martin; W Sun; D Moraga-A; S M Schuster; D E Wylie
Journal:  Amino Acids       Date:  1993-02       Impact factor: 3.520

6.  Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.

Authors:  Hien Anh Nguyen; Ying Su; Arnon Lavie
Journal:  J Biol Chem       Date:  2016-06-27       Impact factor: 5.157

7.  The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.

Authors:  Wai Kin Chan; Philip L Lorenzi; Andriy Anishkin; Preeti Purwaha; David M Rogers; Sergei Sukharev; Susan B Rempe; John N Weinstein
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

Review 8.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

9.  Natural and asparaginase induced death of L5178Y leukemia cells in vivo.

Authors:  K G Hofer; J DiBenedetto; W L Hughes
Journal:  Z Krebsforsch       Date:  1970-11-20

10.  Asparagine synthetases of Klebsiella aerogenes: properties and regulation of synthesis.

Authors:  L J Reitzer; B Magasanik
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.